Theravance Biopharma (TBPH) Deferred Taxes (2024 - 2026)
Theravance Biopharma (TBPH) reported Deferred Taxes of -$3.0 million for Q1 2026, down 61.93% year-over-year from -$7.9 million in Q1 2025, and down 10096.67% quarter-over-quarter from $30000.0 in Q4 2025.
Theravance Biopharma (TBPH) Deferred Taxes (2024 - 2026) Analysis & Trends
Theravance Biopharma (TBPH) has 3 years of Deferred Taxes data on file, last reported at -$3.0 million in Q1 2026.
- Deferred Taxes for Q1 2026 came in at -$3.0 million, down 61.93% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.7 million (down 42.12% YoY), and the FY2025 annual result was -$11.5 million, down 52.11% from the prior year.
- Deferred Taxes declined to -$3.0 million in Q1 2026 per TBPH's latest filing, from $30000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $994000.0 in Q3 2025 and troughed at -$10.7 million in Q2 2025.
- A 3-year average of -$2.5 million and a median of -$561000.0 in 2024 frame the typical range for Deferred Taxes.
- On a YoY basis, Deferred Taxes climbed as much as 1004.44% in 2025 and fell as far as 1805.7% in 2025.
- A 3-year view of Deferred Taxes shows it stood at -$6.6 million in 2024, then surged by 100.46% to $30000.0 in 2025, then sank by 10096.67% to -$3.0 million in 2026.
- Business Quant data shows TBPH's Deferred Taxes at -$3.0 million in Q1 2026, $30000.0 in Q4 2025, and $994000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Theravance Biopharma | 835.85 Mn | 441.18 Mn | - | -3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.00 Mn |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 994,000.00 |
| Jun 30, 2025 | -10.69 Mn |
| Mar 31, 2025 | -1.85 Mn |
| Dec 31, 2024 | -6.59 Mn |
| Sep 30, 2024 | 90,000.00 |
| Jun 30, 2024 | -561,000.00 |
| Mar 31, 2024 | -513,000.00 |